Featured Research

from universities, journals, and other organizations

Psoriasis Poses Greater Risk For Developing Heart Disease, Research Suggests

Date:
November 14, 2006
Source:
Mayo Clinic
Summary:
People with the skin disorder psoriasis are at increased risk for developing heart disease, according to Mayo Clinic researchers presenting new study data at the American College of Rheumatology Annual Meeting on November 14.

People with the skin disorder psoriasis are at increased risk for developing heart disease, according to Mayo Clinic researchers presenting new study data at the American College of Rheumatology Annual Meeting on Nov. 14. Although psoriasis is traditionally viewed as a skin disorder, recent research has led experts to categorize this disease as a systemic inflammatory or immune-mediated disorder. In these disorders, the immune cells attack healthy tissues and organs.

Earlier research has shown that people with autoimmune diseases, such as rheumatoid arthritis and lupus, are at increased risk for heart disease. To study whether a similar risk exists for people with psoriasis, Mayo researchers followed a group of 622 adults with psoriasis and a control group of 622 people, matched for age and gender, who did not have the disease. Researchers examined medical records for subjects in both groups, starting from age 18 until death, and noted the occurrence of heart attack (myocardial infarction) and heart failure in both groups.

Significant Findings Mayo researchers found that the people diagnosed with psoriasis experienced heart attacks more than twice as often as people of the same gender and age in the control group. Those with psoriasis also appeared about 1.42 times more likely to develop heart failure; subjects with psoriasis also appeared about 1.42 times more likely to develop heart failure, but these results were not statistically significant.

"The fact that people with psoriasis exhibit this increased risk for heart disease offers additional proof that psoriasis is a systemic inflammatory disease rather than just a skin disorder," says Sherine Gabriel, M.D., Mayo Clinic epidemiologist and the study's lead researcher.

Mayo researchers hope that these preliminary results may yield additional clues about the mechanisms that contribute to cardiovascular disease.

"We're now seeing increased risk for heart disease associated with a broad range of systemic diseases, all of which share a high level of inflammation and immune system dysfunction," says Dr. Gabriel. "This knowledge could provide us with a better understanding of the connections between these conditions and their underlying causes."

The Mayo research findings also emphasize the need for psoriasis patients to monitor their cardiovascular health at an earlier age and to take measures to lessen their risks for heart attack, heart failure and other cardiovascular problems.

Future research will focus on explaining the potential drivers of this risk by studying the role of cardiovascular risk factors (such as smoking), medications, and biological factors (such as genetics). Facts about psoriasis

Psoriasis is marked by patches of thick, red skin covered with silvery scales that occur primarily on the elbows, knees, legs, lower back and scalp. Although not life threatening, the disease can be painful, affect a person's ability to function, and cause psychological and emotional distress. Facts about heart attack and heart failure

Heart attack is an injury to the heart muscle caused by a loss of blood supply. It usually occurs when a blood clot blocks the flow of blood through a coronary artery -- a blood vessel that feeds blood to a part of the heart muscle. Heart failure, also known as congestive heart failure, usually occurs when coronary artery disease or high blood pressure cause the heart muscle to become too weak or too stiff to pump efficiently.

The Mayo Clinic research team also included Hilal Maradit Kremers, M.D., Marian McEvoy, M.D., and Cynthia Crowson. This work was supported in part by grants from Amgen Inc. and the National Institute of Arthritis and Musculoskeletal and Skin Diseases.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Psoriasis Poses Greater Risk For Developing Heart Disease, Research Suggests." ScienceDaily. ScienceDaily, 14 November 2006. <www.sciencedaily.com/releases/2006/11/061113170801.htm>.
Mayo Clinic. (2006, November 14). Psoriasis Poses Greater Risk For Developing Heart Disease, Research Suggests. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2006/11/061113170801.htm
Mayo Clinic. "Psoriasis Poses Greater Risk For Developing Heart Disease, Research Suggests." ScienceDaily. www.sciencedaily.com/releases/2006/11/061113170801.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins